公开(公告)号：WO2022263622A2

公开(公告)日：2022-12-22

申请号：PCT/EP2022/066537

申请日：2022-06-17

Applicant: MERZ PHARMA (SCHWEIZ) AG

Inventor： WILDI, Eckhart

IPC: A61J7/04 ,  G16H20/13 ,  A61M35/00 ,  A61B5/00 ,  G06T7/00 ,  A45D44/00 ,  A61B5/107 ,  A45D2034/002 ,  A45D2044/007 ,  A45D34/00 ,  A61B2576/00 ,  A61B5/002 ,  A61B5/0077 ,  A61B5/441 ,  A61B5/445 ,  A61B5/4833 ,  A61B5/6898 ,  A61B5/7485 ,  A61J2200/30 ,  A61J2200/70 ,  A61J7/0076 ,  A61J7/0418 ,  A61J7/0436 ,  A61J7/0481 ,  G06T2207/10024 ,  G06T2207/30088 ,  G06T7/0012 ,  G16H40/63

Abstract: An application compliance device (1) for monitoring a customized dosage regime of a skin care product provided in a container device (20). It comprises a housing (2) for receiving the container device (20). The device comprises a control unit, a sensor unit for sensing a quantity of the skin care product administered from the container device (1) and a signal unit. The control unit is configured to evaluate a quantity signal received from the sensor unit to determine an administered dosage quantity, to control the signal unit to generate a compliant signal if the administered dosage quantity is compliant with the customized dosage regime, to generate a partly compliant signal if the administered dosage quantity is not compliant with the dosage regime for a first time, and to generate a warning signal if the administered dosage quantity is not compliant with the dosage regime for a second time.